Unicycive Therapeutics
UNCY
9 hedge funds and large institutions have $428K invested in Unicycive Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.
0.12% less ownership
Funds ownership: 0.64% → 0.53% (-0.12%)
25% less capital invested
Capital invested by funds: $571K → $428K (-$143K)
25% less funds holding
Funds holding: 12 → 9 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$10.5K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ayrton Capital
Westport,
Connecticut
|
-$45K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$42.7K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$11K |
| 4 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$9K |
| 5 |
Renaissance Technologies
New York
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
| $350K | -$42.7K | -6,312 | -9% |
|
|
BOTOTLSJU
2
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
| $34K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $13K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $12.3K | – | – | – |
|
|
TCM
5
Tandem Capital Management
Woodcliff Lake,
New Jersey
| $8.37K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $8K | +$10.5K | +1,546 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | -$122 | -18 | -3% |
|
8
Wells Fargo
San Francisco,
California
| $25 | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $5 | +$7 | +1 | New |
|
|
AC
10
Ayrton Capital
Westport,
Connecticut
| – | -$45K | -7,665 | Closed |
|
|
11
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$11K | -1,880 | Closed |
|
|
FNBT
12
FineMark National Bank & Trust
Fort Myers,
Florida
| – | -$9K | -1,563 | Closed |
|
|
13
Renaissance Technologies
New York
| – | -$8K | -1,290 | Closed |
|
14
UBS Group
Zurich,
Switzerland
| – | -$1K | -119 | Closed |
|
UNCY Hedge Fund Activity: Q4 2022 in Review
9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Unicycive Therapeutics (UNCY) for Q4 2022, worth a combined $428K — down 25% from $571K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of UNCY and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $10.5K. The largest seller was Ayrton Capital, exiting entirely with an estimated $45K sold.
- 9 institutional investors held Unicycive Therapeutics (UNCY) as of Q4 2022, down from 12 in Q3 2022.
- Funds reported $428K of Unicycive Therapeutics stock for Q4 2022, down 25% quarter-over-quarter.
- 2 funds opened new Unicycive Therapeutics positions in Q4 2022 and 5 closed out, a net change of -3 holders.
- The largest Unicycive Therapeutics buyer in Q4 2022 was Virtu Financial, an estimated $10.5K added.
- The largest Unicycive Therapeutics seller in Q4 2022 was Ayrton Capital, an estimated $45K sold.
Based on aggregated 13F filings for Q4 2022.